CAF–CM remarkably increased the phosphorylation of STAT3 in ICC cell lines, but the increasing effects on CAF phosphorylation were eliminated by nintedanib treatment (Fig. 4c). Here, STAT3 is linked to intrahepatic cholangiocarcinoma.